###begin article-title 0
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse
###end article-title 0
###begin p 1
###xml 416 421 <span type="species:ncbi:10090">mouse</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
Syncoilin is a 64-kDa intermediate filament protein expressed in skeletal muscle and enriched at the perinucleus, sarcolemma, and myotendinous and neuromuscular junctions. Due to its pattern of cellular localization and binding partners, syncoilin is an ideal candidate to be both an important structural component of myocytes and a potential mediator of inherited myopathies. Here we present a report of a knockout mouse model for syncoilin and the results of an investigation into the effect of a syncoilin null state on striated muscle function in 6-8-week-old mice. An analysis of proteins known to associate with syncoilin showed that ablation of syncoilin had no effect on absolute expression or spatial localization of desmin or alpha dystrobrevin. Our syncoilin-null animal exhibited no differences in cardiotoxin-induced muscle regeneration, voluntary wheel running, or enforced treadmill exercise capacity, relative to wild-type controls. Finally, a mechanical investigation of isolated soleus and extensor digitorum longus indicated a potential differential reduction in muscle strength and resilience. We are the first to present data identifying an increased susceptibility to muscle damage in response to an extended forced exercise regime in syncoilin-deficient muscle. This study establishes a second viable syncoilin knockout model and highlights the importance of further investigations to determine the role of syncoilin in skeletal muscle.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 635 639 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 653 657 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2002</xref>
###xml 855 859 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2007</xref>
###xml 874 878 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 892 896 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2002</xref>
###xml 267 273 <span type="species:ncbi:9606">humans</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 446 451 <span type="species:ncbi:4932">yeast</span>
Syncoilin is a recently described member of the intermediate filament (IF) family of proteins (Newey et al. 2001). So named for its enrichment at the neuromuscular synapse and its coiled-coil-forming rod domains, the syncoilin gene has been mapped to chromosome 1 in humans and to chromosome 4 in mice. The syncoilin gene comprises five coding exons that generate a 64-kDa protein product (Newey et al. 2001). Following its discovery, subsequent yeast two-hybrid screening analysis showed that the IF protein desmin and the dystrophin-related protein alpha-dystrobrevin were syncoilin binding partners in striated muscle (Newey et al. 2001; Poon et al. 2002). Histologic studies utilizing immunofluorescent and confocal microscopy have confirmed that syncoilin colocalizes under normal conditions with both desmin and alpha-dystrobrevin (McCullagh et al. 2007; Newey et al. 2001; Poon et al. 2002).
###end p 3
###begin p 4
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2005</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2002</xref>
One distinctive feature of syncoilin is its apparent departure from spontaneous dimer-forming behavior. Syncoilin does not appear to form a filamentous network by itself or with other IF proteins, although it may form filaments in certain myopathies (Brown et al. 2005; Poon et al. 2002).
###end p 4
###begin p 5
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2007</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2002</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2007</xref>
Syncoilin is highly expressed in skeletal and cardiac muscle, and in the former it is concentrated at the sarcolemma, Z-lines, perinuclear space, myotendinous junction, and neuromuscular junction (McCullagh et al. 2007; Newey et al. 2001; Poon et al. 2002). Within the skeletal muscle fiber population, syncoilin is enriched at the sarcolemma and sarcoplasm of oxidative muscle fibers (McCullagh et al. 2007). Thus, the localization of syncoilin parallels that of desmin, to which it binds directly.
###end p 5
###begin p 6
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2007</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2004</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">2008</xref>
Desmin is the dominant IF protein in mature muscle and has been predicted to play a major role in protecting muscle from mechanical stress and is important for muscle integrity (Capetanaki et al. 2007; Costa et al. 2004). An analysis of the tensile properties of single desmin filaments has shown that it exhibits a nonlinear response to strain (notably above 50% extension) and a tensile strength of at least 240 mPa (Kreplak et al. 2008). These properties add further weight to the theory that desmin acts as both a mediator of myocyte spatial organization and provides a physical link between adjacent contractile units.
###end p 6
###begin p 7
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">1996</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">1996</xref>
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2004</xref>
###xml 268 274 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 138 144 <span type="species:ncbi:9606">humans</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
Desmin knockout (des-/-) mice show a skeletal myopathy as well as a cardiomyopathy, and desmin aberrations have been linked to disease in humans (Li et al. 1996; Milner et al. 1996; Olive et al. 2004). A study of exercise ability showed a reduction in the capacity of des-/- mice to perform both voluntary wheel running and enforced treadmill exercise. Most interestingly, the study showed that an absence of desmin was not sufficient to increase serum creatine kinase levels (a marker of sarcolemmal damage) (Haubold et al. 2003).
###end p 7
###begin p 8
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2007</xref>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">2005</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
We have previously shown that the levels of syncoilin are reduced by 60% in these animals and that the subcellular location of syncoilin is altered. In the des-/- mice, syncoilin is lost from the Z-lines and reduced at the sarcolemma (McCullagh et al. 2007). Alterations in syncoilin expression have been reported for other myopathies, including elevated levels in dystrophic muscles of mdx mice and in atrophic muscle fibers of patients with neurogenic disorders (Brown et al. 2005; Newey et al. 2001).
###end p 8
###begin p 9
###xml 573 577 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2002</xref>
Although there is clear evidence showing that syncoilin binds directly to both alpha-dystrobrevin and desmin, whether syncoilin has the ability to bind to these proteins simultaneously and thus form a link between the cytoskeletal IF network and the sarcolemma via the dystrophin associated protein complex (DAPC) remains to be investigated. This potential linking of the DAPC to the IF network via syncoilin is of interest since the lateral transmission of contractile force to the extracellular matrix is believed to be mediated mainly through IF proteins (Lieber et al. 2002).
###end p 9
###begin p 10
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2002</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2002</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2006</xref>
The DAPC is a trans-sarcolemmal protein complex expressed in both muscle and nonmuscle tissues (Blake et al. 2002). Due to its expression patterns and its large and varied number of protein constituents, the DAPC is considered to play both a structural and a signaling role. A detailed review of the DAPC with respect to its structure and predicted role in normal skeletal muscle function and myopathy is outside of the scope of this article. The reader is referred to comprehensive reviews by Blake et al. (2002) and Davies and Nowak (2006) for further detail.
###end p 10
###begin p 11
###xml 506 510 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2007</xref>
###xml 525 529 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2003</xref>
###xml 545 549 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2004</xref>
###xml 563 567 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">2007</xref>
###xml 917 921 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2002</xref>
Briefly, the DAPC consists of the alpha- and beta-dystroglycans and the sarcoglycans at the sarcolemma, along with the cytoplasmic components syntrophin and dystrobrevin. It is now well established that mutations in dystrophin and the sarcoglycans result in a muscular dystrophy. Aberrations in both desmin and alpha-dystrobrevin have been implicated in muscular dystrophies, although in the case of alpha-dystrobrevin its role in the pathophysiology of neuromuscular disease is far from clear (Jin et al. 2007; Jones et al. 2003; Paulin et al. 2004; Rees et al. 2007). The DAPC stabilizes the sarcolemma by linking the extracellular matrix (via an extracellular interaction of laminin-2 with DAPC component alpha-dystroglycan) with the internal cytoskeleton and contractile apparatus of myocytes (via an interaction of dystrophin with F-actin and indirectly with the IF network via alpha-dystrobrevin) (Blake et al. 2002).
###end p 11
###begin p 12
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync</italic>
###xml 648 654 648 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">floxed</italic>
###xml 684 691 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 961 968 961 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 764 769 <span type="species:ncbi:10090">mouse</span>
###xml 969 974 <span type="species:ncbi:10090">mouse</span>
In view of the findings that the loss of either desmin or dystrobrevin results in the development of muscular dystrophy in association with changes in the distribution of syncoilin, we decided to test the hypothesis that loss of syncoilin might have an adverse effect on myocyte function. We generated a syncoilin knockout mouse by standard techniques of homologous recombination in embryonic stem (ES) cells and a Cre-loxP-mediated conditional gene-targeting approach. Such null mutants would allow the investigation of the role of syncoilin in skeletal and cardiac muscle. This strategy allowed us to produce two lines of mice: conditional (sync-floxed) and constitutive syncoilin (sync-/-) knockout mice. Constitutive deletion of syncoilin resulted in a viable mouse, precluding the need for tissue-specific excision of the syncoilin gene. In this article we present the results of a molecular and phenotypic characterization of striated muscle from a novel sync-/- mouse.
###end p 12
###begin title 13
Materials and methods
###end title 13
###begin title 14
Animals and antibodies
###end title 14
###begin p 15
###xml 350 354 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">1998</xref>
###xml 396 400 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2001</xref>
###xml 415 419 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 686 690 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2004</xref>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
All mice were bred in-house and genotyped by standard PCR methods. All animal experiments were performed according to guidelines and protocols approved by the Home Office. Antibodies used were anti-syncoilin-FP 81, anti-desmin (Abcam8592), anti-desmin monoclonal antibody (DE-U-10; Sigma), anti-dystrobrevin-1 and -2 antibody beta1CTFP (Blake et al. 1998), anti-dysbindin antibody (Benson et al. 2001; Newey et al. 2001), anti-alpha-actinin mouse (N40; Santa Cruz), anti-alpha-actinin antibody (EA-53; Sigma) and anti-dystrophin antibody (Dys-2; Novacastro). A synemin antibody (anti-Syn-3) that detects both alpha- and beta-synemin was generated as previously described (Mizuno et al. 2004).
###end p 15
###begin title 16
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Gene targeting and generation of syncoilin knockout mice
###end title 16
###begin p 17
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 436 439 436 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">frt</italic>
###xml 536 539 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 653 655 653 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sv</italic>
###xml 846 849 846 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 947 948 947 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 994 1000 994 1000 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1034 1035 1034 1035 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1464 1467 1464 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 1478 1481 1478 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 1541 1544 1541 1544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 1584 1587 1584 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">frt</italic>
###xml 1610 1613 1610 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flp</italic>
###xml 2117 2120 2117 2120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 2289 2290 2289 2290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2309 2312 2309 2312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 2506 2507 2506 2507 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2782 2783 2782 2783 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2925 2926 2925 2926 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3134 3141 3134 3141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 3155 3162 3155 3162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 1000 3236 1000 3236 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18">Targeting of the syncoilin gene. (<bold>a</bold>) The top of the diagram shows the targeting DNA vector with relevant restriction sites, constructed by subcloning genomic syncoilin fragments, a pgk-Neo-positive selection cassette, and a CMV-DTA-negative selection cassette into a modified pBluescript vector. The genomic syncoilin fragments (short 5&#8242; arm and long 3&#8242; arm) were PCR amplified from a bacterial artificial chromosome. The long &#8220;arm&#8221; was modified by insertion of a <italic>lox</italic>P site and <italic>Nco</italic>I restriction site after exon 2. Filled boxes depict exons, <italic>lox</italic>P sites are shown as filled arrows, and <italic>frt</italic> in open boxes signify <italic>flp</italic> recombinase sites. The second diagram is the relevant genomic locus of syncoilin. Probes used for Southern blotting analysis of homologous recombination events are shown as black bars below intronic and exon regions; ext, external probe; int, internal probe; and ex2, exon 2 probe. Primers used to genotype mice are shown as horizontal arrows. The third diagram represents the conditional (floxed) allele after homologous recombination in ES cells. The bottom diagram shows the allele after in vivo Cre-<italic>lox</italic>P-mediated deletion of exon 2. PGK-Neo, neomyocin gene under the phosphoglycerine kinase promoter; CMV-DTA, diphtheria toxin A gene under the cytomegalovirus promoter. (<bold>b</bold>) Southern blot of <italic>Nco</italic>I-digested genomic DNA from two correctly targeted ES clones (+/&#8722;) and a wild-type (+/+) clone. The upper panel shows the autoradiography after hybridization with a 3&#8242; external probe, shown in (<bold>a</bold>). The 8.2-kb and 6.28-kb bands represent the expected wild-type and targeted alleles, respectively. The lower panel shows the same clones reprobed with a 5&#8242; internal probe and expected bands 2.3 kb and 3.5&#160;kb were detected for wild-type and targeted alleles, respectively. (<bold>c</bold>) Representative PCR genotype for wild-type (+/+), heterozygous (+/&#8722;), and homozygous (&#8722;/&#8722;) mice using a triple primer set shown in panel A. (<bold>d</bold>) RT-PCR analysis of RNA extracted from tibialis anterior muscle (TA), soleus (Sol), and heart (Hrt) using primers from exons 2&#160;and 5&#160;of the syncoilin gene (see Methods). A 500-bp fragment was amplified from <italic>sync+/+</italic> but not from <italic>sync&#8722;/&#8722;</italic> mouse RNA. GAPDH primers were included as a control for the cDNA template</p>
###xml 1000 3236 1000 3236 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18">Targeting of the syncoilin gene. (<bold>a</bold>) The top of the diagram shows the targeting DNA vector with relevant restriction sites, constructed by subcloning genomic syncoilin fragments, a pgk-Neo-positive selection cassette, and a CMV-DTA-negative selection cassette into a modified pBluescript vector. The genomic syncoilin fragments (short 5&#8242; arm and long 3&#8242; arm) were PCR amplified from a bacterial artificial chromosome. The long &#8220;arm&#8221; was modified by insertion of a <italic>lox</italic>P site and <italic>Nco</italic>I restriction site after exon 2. Filled boxes depict exons, <italic>lox</italic>P sites are shown as filled arrows, and <italic>frt</italic> in open boxes signify <italic>flp</italic> recombinase sites. The second diagram is the relevant genomic locus of syncoilin. Probes used for Southern blotting analysis of homologous recombination events are shown as black bars below intronic and exon regions; ext, external probe; int, internal probe; and ex2, exon 2 probe. Primers used to genotype mice are shown as horizontal arrows. The third diagram represents the conditional (floxed) allele after homologous recombination in ES cells. The bottom diagram shows the allele after in vivo Cre-<italic>lox</italic>P-mediated deletion of exon 2. PGK-Neo, neomyocin gene under the phosphoglycerine kinase promoter; CMV-DTA, diphtheria toxin A gene under the cytomegalovirus promoter. (<bold>b</bold>) Southern blot of <italic>Nco</italic>I-digested genomic DNA from two correctly targeted ES clones (+/&#8722;) and a wild-type (+/+) clone. The upper panel shows the autoradiography after hybridization with a 3&#8242; external probe, shown in (<bold>a</bold>). The 8.2-kb and 6.28-kb bands represent the expected wild-type and targeted alleles, respectively. The lower panel shows the same clones reprobed with a 5&#8242; internal probe and expected bands 2.3 kb and 3.5&#160;kb were detected for wild-type and targeted alleles, respectively. (<bold>c</bold>) Representative PCR genotype for wild-type (+/+), heterozygous (+/&#8722;), and homozygous (&#8722;/&#8722;) mice using a triple primer set shown in panel A. (<bold>d</bold>) RT-PCR analysis of RNA extracted from tibialis anterior muscle (TA), soleus (Sol), and heart (Hrt) using primers from exons 2&#160;and 5&#160;of the syncoilin gene (see Methods). A 500-bp fragment was amplified from <italic>sync+/+</italic> but not from <italic>sync&#8722;/&#8722;</italic> mouse RNA. GAPDH primers were included as a control for the cDNA template</p></caption>
###xml 3236 3236 3236 3236 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="335_2008_9120_Fig1_HTML" id="MO1"/>
###xml 994 3236 994 3236 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="18">Targeting of the syncoilin gene. (<bold>a</bold>) The top of the diagram shows the targeting DNA vector with relevant restriction sites, constructed by subcloning genomic syncoilin fragments, a pgk-Neo-positive selection cassette, and a CMV-DTA-negative selection cassette into a modified pBluescript vector. The genomic syncoilin fragments (short 5&#8242; arm and long 3&#8242; arm) were PCR amplified from a bacterial artificial chromosome. The long &#8220;arm&#8221; was modified by insertion of a <italic>lox</italic>P site and <italic>Nco</italic>I restriction site after exon 2. Filled boxes depict exons, <italic>lox</italic>P sites are shown as filled arrows, and <italic>frt</italic> in open boxes signify <italic>flp</italic> recombinase sites. The second diagram is the relevant genomic locus of syncoilin. Probes used for Southern blotting analysis of homologous recombination events are shown as black bars below intronic and exon regions; ext, external probe; int, internal probe; and ex2, exon 2 probe. Primers used to genotype mice are shown as horizontal arrows. The third diagram represents the conditional (floxed) allele after homologous recombination in ES cells. The bottom diagram shows the allele after in vivo Cre-<italic>lox</italic>P-mediated deletion of exon 2. PGK-Neo, neomyocin gene under the phosphoglycerine kinase promoter; CMV-DTA, diphtheria toxin A gene under the cytomegalovirus promoter. (<bold>b</bold>) Southern blot of <italic>Nco</italic>I-digested genomic DNA from two correctly targeted ES clones (+/&#8722;) and a wild-type (+/+) clone. The upper panel shows the autoradiography after hybridization with a 3&#8242; external probe, shown in (<bold>a</bold>). The 8.2-kb and 6.28-kb bands represent the expected wild-type and targeted alleles, respectively. The lower panel shows the same clones reprobed with a 5&#8242; internal probe and expected bands 2.3 kb and 3.5&#160;kb were detected for wild-type and targeted alleles, respectively. (<bold>c</bold>) Representative PCR genotype for wild-type (+/+), heterozygous (+/&#8722;), and homozygous (&#8722;/&#8722;) mice using a triple primer set shown in panel A. (<bold>d</bold>) RT-PCR analysis of RNA extracted from tibialis anterior muscle (TA), soleus (Sol), and heart (Hrt) using primers from exons 2&#160;and 5&#160;of the syncoilin gene (see Methods). A 500-bp fragment was amplified from <italic>sync+/+</italic> but not from <italic>sync&#8722;/&#8722;</italic> mouse RNA. GAPDH primers were included as a control for the cDNA template</p></caption><graphic position="anchor" xlink:href="335_2008_9120_Fig1_HTML" id="MO1"/></fig>
###xml 970 975 <span type="species:ncbi:10090">mouse</span>
###xml 1224 1227 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1921 1925 <span type="species:ncbi:10090">mice</span>
###xml 2219 2222 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 2875 2879 <span type="species:ncbi:10090">mice</span>
###xml 3163 3168 <span type="species:ncbi:10090">mouse</span>
The targeting construct is shown in Fig. 1. Genomic regions of the syncoilin gene were amplified by PCR from a 129/Sv bacterial artificial plasmid (Wellcome Trust Sanger Institute, Cambridge, UK) which contained the syncoilin locus. The targeting construct was assembled in the pBluescript II KS+ vector. The 5' arm of homology consisted of a 1.6-kb fragment upstream of syncoilin exon 2 followed by a loxP site and neomycin flanked by frt recombinase sites. The 3' arm of homology was a 5.9-kb fragment containing exon 2 followed by a loxP site. The targeting vector was verified by sequencing and linearized with NotI before electroporation into E129/sv ES cells. Four hundred G418-resistant ES clones were selected for screening for homologous recombination by PCR and Southern blotting. Genomic DNA isolated from each clone was digested with NcoI and analyzed by Southern blotting. A 5' internal probe and 3' external probe (indicated in Fig. 1) were generated from mouse E129 genomic DNA. Fig. 1Targeting of the syncoilin gene. (a) The top of the diagram shows the targeting DNA vector with relevant restriction sites, constructed by subcloning genomic syncoilin fragments, a pgk-Neo-positive selection cassette, and a CMV-DTA-negative selection cassette into a modified pBluescript vector. The genomic syncoilin fragments (short 5' arm and long 3' arm) were PCR amplified from a bacterial artificial chromosome. The long "arm" was modified by insertion of a loxP site and NcoI restriction site after exon 2. Filled boxes depict exons, loxP sites are shown as filled arrows, and frt in open boxes signify flp recombinase sites. The second diagram is the relevant genomic locus of syncoilin. Probes used for Southern blotting analysis of homologous recombination events are shown as black bars below intronic and exon regions; ext, external probe; int, internal probe; and ex2, exon 2 probe. Primers used to genotype mice are shown as horizontal arrows. The third diagram represents the conditional (floxed) allele after homologous recombination in ES cells. The bottom diagram shows the allele after in vivo Cre-loxP-mediated deletion of exon 2. PGK-Neo, neomyocin gene under the phosphoglycerine kinase promoter; CMV-DTA, diphtheria toxin A gene under the cytomegalovirus promoter. (b) Southern blot of NcoI-digested genomic DNA from two correctly targeted ES clones (+/-) and a wild-type (+/+) clone. The upper panel shows the autoradiography after hybridization with a 3' external probe, shown in (a). The 8.2-kb and 6.28-kb bands represent the expected wild-type and targeted alleles, respectively. The lower panel shows the same clones reprobed with a 5' internal probe and expected bands 2.3 kb and 3.5 kb were detected for wild-type and targeted alleles, respectively. (c) Representative PCR genotype for wild-type (+/+), heterozygous (+/-), and homozygous (-/-) mice using a triple primer set shown in panel A. (d) RT-PCR analysis of RNA extracted from tibialis anterior muscle (TA), soleus (Sol), and heart (Hrt) using primers from exons 2 and 5 of the syncoilin gene (see Methods). A 500-bp fragment was amplified from sync+/+ but not from sync-/- mouse RNA. GAPDH primers were included as a control for the cDNA template
###end p 17
###begin p 18
###xml 34 35 34 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 464 467 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 478 481 478 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 541 544 541 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 584 587 584 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">frt</italic>
###xml 610 613 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flp</italic>
###xml 1117 1120 1117 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 1289 1290 1289 1290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1309 1312 1309 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 1506 1507 1506 1507 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1782 1783 1782 1783 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1925 1926 1925 1926 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 2134 2141 2134 2141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 2155 2162 2155 2162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 224 227 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
###xml 1219 1222 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1875 1879 <span type="species:ncbi:10090">mice</span>
###xml 2163 2168 <span type="species:ncbi:10090">mouse</span>
Targeting of the syncoilin gene. (a) The top of the diagram shows the targeting DNA vector with relevant restriction sites, constructed by subcloning genomic syncoilin fragments, a pgk-Neo-positive selection cassette, and a CMV-DTA-negative selection cassette into a modified pBluescript vector. The genomic syncoilin fragments (short 5' arm and long 3' arm) were PCR amplified from a bacterial artificial chromosome. The long "arm" was modified by insertion of a loxP site and NcoI restriction site after exon 2. Filled boxes depict exons, loxP sites are shown as filled arrows, and frt in open boxes signify flp recombinase sites. The second diagram is the relevant genomic locus of syncoilin. Probes used for Southern blotting analysis of homologous recombination events are shown as black bars below intronic and exon regions; ext, external probe; int, internal probe; and ex2, exon 2 probe. Primers used to genotype mice are shown as horizontal arrows. The third diagram represents the conditional (floxed) allele after homologous recombination in ES cells. The bottom diagram shows the allele after in vivo Cre-loxP-mediated deletion of exon 2. PGK-Neo, neomyocin gene under the phosphoglycerine kinase promoter; CMV-DTA, diphtheria toxin A gene under the cytomegalovirus promoter. (b) Southern blot of NcoI-digested genomic DNA from two correctly targeted ES clones (+/-) and a wild-type (+/+) clone. The upper panel shows the autoradiography after hybridization with a 3' external probe, shown in (a). The 8.2-kb and 6.28-kb bands represent the expected wild-type and targeted alleles, respectively. The lower panel shows the same clones reprobed with a 5' internal probe and expected bands 2.3 kb and 3.5 kb were detected for wild-type and targeted alleles, respectively. (c) Representative PCR genotype for wild-type (+/+), heterozygous (+/-), and homozygous (-/-) mice using a triple primer set shown in panel A. (d) RT-PCR analysis of RNA extracted from tibialis anterior muscle (TA), soleus (Sol), and heart (Hrt) using primers from exons 2 and 5 of the syncoilin gene (see Methods). A 500-bp fragment was amplified from sync+/+ but not from sync-/- mouse RNA. GAPDH primers were included as a control for the cDNA template
###end p 18
###begin p 19
Southern blots were hybridized with radiolabeled probes and visualized by autoradiography. The 5' internal probe was used to confirm recombination of the 5' arm of the targeting vector, where the wild-type allele is indicated by a band at 2.3 kb, and a 3.5-kb band represents the correctly targeted allele. Hybridization of blots with the 3' external probe was used to verify recombination of the 3' arm of the targeting vector, where the wild-type allele is represented by a band at 8.2 kb, and a 6.3-kb band represents the correctly targeted allele.
###end p 19
###begin title 20
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Generation and genotyping of mice
###end title 20
###begin p 21
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/&#8722;</italic>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sync+/&#8722;</italic>
###xml 369 376 369 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 129 144 <span type="species:ncbi:10090">transgenic mice</span>
###xml 221 224 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
Two independent correctly targeted ES clones were microinjected into blastocysts from C57BL/6 mice. Chimeric mice were bred with transgenic mice ubiquitously expressing Cre recombinase under the cytomegalovirus promoter (CMV), to generate germline-transmitted syncoilin heterozygous (sync+/-) mice. Sync+/- mice were intercrossed to generate homozygous syncoilin null (sync-/-) mice. Offspring from intercrosses were genotyped by PCR analysis of mouse tail DNA using the following primers: forward (wtFw), 5'-ATGAAGTGATGTAAGCAGAGACTAGC-3'; reverse(wtRv), 5'-GATAGAGAATGTCCTCTAGGTTCACAG-3'; deletion indicator primer (DeltaEx2Rv), 5'-TCCTAATCCTAACCCTACCCTAACTAA-3'.
###end p 21
###begin title 22
RNA extraction and RT-PCR
###end title 22
###begin p 23
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Total RNA was prepared from skeletal and cardiac muscle of sync+/+ and sync-/- mice. Dissected tissue was snap-frozen and milled in liquid nitrogen immediately before total RNA extraction using Trizol (Invitrogen) according to the manufacturer's instructions. Total RNA (300 ng) was reverse-transcribed into cDNA using random decameric primers and superscript II reverse transcriptase (Invitrogen). Generated cDNA was used as a template to perform standard PCR analysis.
###end p 23
###begin p 24
###xml 209 216 209 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
Specific primers annealing to exon 2 and exon 5 (forward, 5'-AACTTCAGAACAGGAACCTGGAGGAC-3'; reverse, 5'-CACTGAAATCAGTACCAGCAGCCTAC-3') were used to amplify and test for the presence of syncoilin transcript in sync+/+ and sync-/- muscles. Standard exonic GAPDH primers were run on duplicate samples as a control for the cDNA template.
###end p 24
###begin title 25
Protein preparation and immunoblotting
###end title 25
###begin p 26
###xml 794 805 <span type="species:ncbi:3704">horseradish</span>
Skeletal or cardiac muscles were snap-frozen immediately after dissection in liquid nitrogen and stored at -80degreesC until use. The tissue was homogenized in 300 mul cold Newcastle buffer (75 mM Tris pH 6.8, 3.8% SDS, 4 M urea, and 20% glycerol) with protease inhibitor cocktail (Sigma). Protein quantification was performed using the Bio-Rad Dc Protein Assay according to the manufacturer's protocol. Total protein (40 mug) was separated on 8 or 10% SDS polyacrylamide gels (Bio-Rad) and electrophoretically transferred to nitrocellulose membranes. After blocking membranes overnight at 4degreesC in Tris-buffered saline containing 0.1% (v/v) Tween20 (TBS-T) and 5% nonfat dry milk, blots were incubated for 1 h with primary antibody and washed three times in TBS-T prior to incubation with horseradish peroxidase conjugated IgG in blocking buffer. Membranes were washed as previously described and developed using ECL detection reagents (Amersham) as per the manufacturer's instructions. Blots were stripped at 50degreesC for reprobing with different antibodies. Exposed film was scanned with a HP Scanjet 5400c.
###end p 26
###begin title 27
Single myofiber preparations
###end title 27
###begin p 28
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">2002</xref>
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">2004</xref>
###xml 288 289 288 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 300 301 300 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 310 311 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 732 733 726 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse flexor digitorum brevis muscles (FDBs) were enzymatically dissociated using an established protocol (Brown and Schneider 2002; Woods et al. 2004). The FDB was dissected free and placed into 1 mg/ml of collagenase (Type 1, Sigma) in Ringer buffer (119 mM NaCl, 5 mM KCl, 1.25 mM CaCl2, 1 mM MgSO4, 1 mM KH2PO4, 10 mM glucose) at 37degreesC for 1.5 h. Collagenase activity was stopped by washing the muscle with warmed Ringer's solution and the muscle was gently triturated using a Pasteur pipette until single fibers were isolated. One hundred fifty microliters of Ringer's solution containing FDB single fibers was spread across laminin-coated glass bottom culture dishes (Matek Corp., Part No P35G-1.0) and incubated in 5% CO2 at 37degreesC. After 2 h, Ringer's solution was removed and the dish was flooded with 4% PFA/PBS for 5 min to fix the fibers. This method yielded approximately 100-200 fibers per dish. The fibers were then permeabilized in 0.1% Triton/PBS and then processed for immunolabeling.
###end p 28
###begin p 29
Primary antibodies were diluted in PBS containing 10% FCS and applied to the fiber preparations. After an overnight incubation at 4degreesC, fiber preparations were rinsed in PBS followed by incubation with secondary antibodies (Molecular Probes); Alexa fluor 594 and/or Alexa fluor 488 conjugated IgG diluted (1:2000) in PBS, 10% FCS for 2 h at room temperature. Finally, fiber preparations were washed thoroughly in PBS and mounted in an aqueous medium (VectorShield) with DAPI. Finished preparations were viewed under a Zeiss fluorescent photomicroscope or Zeiss 410 confocal laser-scanning microscope. Digital images were extracted using Axiovision LE 4.3 software.
###end p 29
###begin title 30
Measurement of contractile properties
###end title 30
###begin p 31
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">1993</xref>
###xml 438 439 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 445 446 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 530 531 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 558 559 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 573 574 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 586 587 586 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 589 590 589 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 448 453 <span type="species:ncbi:10090">mouse</span>
Mechanical measurements of skeletal muscle performance in vitro were performed using a previously described protocol (with minor adaptations) (Moens et al. 1993). Briefly, extensor digitorum longus (EDL) and soleus muscles were dissected from 8-week-old male mice killed by cervical dislocation. The muscles were pinned out in oxygenated Ringer's solution at room temperature to a length approximating that seen in situ. Oxygenated (95% O2/5% CO2) mouse Ringer's solution (pH 7.4) was made up to include 118 mM NaCl, 24.8 mM NaHCO3, 4.75 mM KCl, 2.54 mM CaCl2, 11.8 mM MgSO4, 11.8 mM KH2PO4, and 10 mM glucose. Muscles were experimented on within 4 h of excision. The freshly dissected muscles were mounted onto the muscle lever of the Intact Muscle Measurement System (Aurora Scientific Inc.) using 5-0 silk suture, and maintained throughout the protocol at room temperature in oxygenated Ringer's solution. The muscles were stimulated using platinum electrodes connected to a Aurora 701B stimulator. The optimum length was identified, and then the maximum isometric tetanic force was measured (EDL, 120 Hz, 500 ms; soleus, 80 Hz, 800 ms). Force measurements were normalized to muscle cross-sectional area. The wet weight of the muscles was recorded at the end of the experiment. Data were captured and analyzed using the DMC/DMA Dynamic Muscle Control and Analysis software (Aurora Scientific Inc.).
###end p 31
###begin title 32
Cardiotoxin-induced damage of hind limb muscle
###end title 32
###begin p 33
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
Sex-matched adult mice were induced and maintained under isofluorane inhalation anesthetic as discussed above. A small incision was made to expose the tibialis anterior. Using a 100-mul insulin syringe, 50 mul of a 10 muM solution of Cardiotoxin 1 (Sigma Aldrich, Dorset, UK) dissolved in sterile PBS was introduced into the muscle belly. The overlying skin was sutured to close the wound. The contralateral limb was treated with an identical volume of PBS to serve as a control. Three mice of each genotype were treated for each timepoint. Following treatment, mice were aged for 1, 3, 5, 7, or 21 days. Treated and control tibialis anterior muscle for histologic analysis was dissected, embedded in OCT, and snap-frozen in liquid nitrogen-cooled isopentane. Treated and control tibialis anterior muscle for RNA analysis was dissected and snap-frozen in liquid nitrogen.
###end p 33
###begin title 34
Morphologic analysis of myoregeneration following cardiotoxin treatment
###end title 34
###begin p 35
OCT-embedded cardiotoxin-treated muscle and PBS-treated tibialis anterior muscle were sectioned on a cryostat to a thickness of 9-12 mum. Sections were air-dried at room temperature, rapidly fixed in absolute ethanol, then stained with hemotoxylin and eosin and mounted in an aqueous mounting media using standard histologic techniques.
###end p 35
###begin title 36
Analysis of myoregeneration marker induction
###end title 36
###begin p 37
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2007</xref>
Total RNA extraction and generation of cDNA from excised cardiotoxin- and PBS-treated tibialis anterior tissue were performed as described above. Semiquantitative PCR analysis of the cell cycle-dependent kinase inhibitors p21CIP1, p27KIP1, p57KIP2 and myogenin was performed as described previously (Koo et al. 2007).
###end p 37
###begin title 38
Measurement of voluntary wheel running activity
###end title 38
###begin p 39
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">Mice</span>
To investigate the effect of syncoilin ablation on activity levels, we monitored voluntary wheel running in two groups (n = 6) of 6-week-old male sync+/+ and sync-/- mice. Mice were placed in individual cages supplemented with a monitored running wheel. Following an acclimatization period of 1 week, the total number of wheel revolutions performed by each animal was electronically recorded for an additional 7-day period using the ClockLab software suite (Actimetrics Software).
###end p 39
###begin title 40
Measurement of enforced treadmill exercise capacity and resultant muscle damage
###end title 40
###begin p 41
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2003</xref>
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 151 158 151 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
Treadmill exercise is a well-established means of analyzing muscle function in rodents (Armand et al. 2003). Two groups of 6-week-old male sync+/+ and sync-/- mice were exercised on a motorized treadmill (Exer6-M, Columbus Instruments). The regimen consisted of 5 days of familiarization running (10 m/min for 15 min), 9 days of endurance running (17 m/min for 45 min), and 1 day of exhaustion running (17 m/min for 45 min followed by an increase in speed of 1 m/min for 15 min). Each of the endurance/exhaustion running stages began with a 5-min warm-up period at a speed of 10 m/min. Animals were rested for 2 days after each 5-day block of running. The weight of each animal was recorded before and after each running session.
###end p 41
###begin p 42
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 733 738 <span type="species:ncbi:10090">mouse</span>
Animals were killed immediately following the final running session and approximately 100 mul of venous blood was collected from the exposed jugular vein. Following a 3-h incubation on wet ice, serum was isolated by centrifugation in a benchtop centrifuge for 5 min at 14,000 rpm. Serum creatine kinase (CK) analysis was performed using a kinetic UV serum analysis according to manufacturer's instructions (OSR6179, Olympus R&D, Ireland). Muscle was dissected for hemotoxylin and eosin staining as described previously. Evans Blue staining of isolated muscle was performed in 1 ml of mouse Ringer's solution supplemented with 0.1% (w/v) Evans Blue dye. Muscle was incubated in solution for 2.5 h at 37degreesC before being washed in mouse Ringer's solution and embedded in OCT as described previously.
###end p 42
###begin title 43
Results
###end title 43
###begin title 44
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Generation of gene-targeted syncoilin-null mice
###end title 44
###begin p 45
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 341 343 341 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sv</italic>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 840 847 840 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/+</italic>
###xml 999 1006 999 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 1059 1060 1059 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1160 1161 1160 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1186 1193 1186 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 1195 1203 1195 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync +/&#8722;</italic>
###xml 1209 1217 1209 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync &#8722;/&#8722;</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
###xml 715 718 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 734 749 <span type="species:ncbi:10090">transgenic mice</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1281 1285 <span type="species:ncbi:10090">mice</span>
We generated homozygous syncoilin knockout (sync-/-) mice by deleting the gene by in vivo Cre-loxP-mediated excision of exon 2, which encodes 85% of the amino acid sequence (Fig. 1a). This strategy was predicted to ensure the ablation of functional syncoilin expression in knockout animals. The targeting vector was electroporated into E129/sv embryonic stem (ES) cells, and 167 clones were screened. Twenty-four clones were identified that had undergone homologous recombination (example shown in Fig. 1a). Two independent clones were each injected into blastocysts from C57BL/6 mice and then reimplanted to generate chimeric mice, bearing the floxed targeted syncoilin allele. Chimeric mice were bred with female CMV-Cre-expressing transgenic mice to excise exon 2 of syncoilin in vivo and give rise to germline-transmitted heterozygous (sync-/+) mice. In vivo mediated excision of exon 2 was verified by PCR genotyping. Heterozygous mice were interbred to generate homozygous syncoilin knockout (sync-/-) mice, which were confirmed by PCR genotyping (Fig. 1c) and RT-PCR analysis for exons 2-5 of RNA from tibialis anterior, soleus, and heart muscles (Fig. 1d). Different genotypes (sync+/+, sync +/-, and sync -/-) were obtained in the expected Mendelian ratio. Syncoilin-null mice were viable and were indistinguishable from their wild-type littermates in appearance, behavior, and body weight.
###end p 45
###begin title 46
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Syncoilin protein analysis in sync-/- mice
###end title 46
###begin p 47
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 522 529 522 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 539 545 539 545 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 545 742 545 742 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">Western blot analysis of syncoilin and associated muscle proteins. Images show altered syncoilin expression in +/+, +/&#8722;, and &#8722;/&#8722; animals, without a resultant change in syncoilin-associated proteins</p>
###xml 545 742 545 742 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48">Western blot analysis of syncoilin and associated muscle proteins. Images show altered syncoilin expression in +/+, +/&#8722;, and &#8722;/&#8722; animals, without a resultant change in syncoilin-associated proteins</p></caption>
###xml 742 742 742 742 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="335_2008_9120_Fig2_HTML" id="MO2"/>
###xml 539 742 539 742 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="48">Western blot analysis of syncoilin and associated muscle proteins. Images show altered syncoilin expression in +/+, +/&#8722;, and &#8722;/&#8722; animals, without a resultant change in syncoilin-associated proteins</p></caption><graphic position="anchor" xlink:href="335_2008_9120_Fig2_HTML" id="MO2"/></fig>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Western blotting analysis of muscle protein from sync-/- mice with a polyclonal-antibody recognizing full-length (FL) syncoilin protein confirmed that we had ablated syncoilin expression (Fig. 2). Immunoblotting of the above muscle samples with an antibody recognizing an amino terminal (N) epitope (amino acids 1-146; encoded by exons 1 and 2), which includes the translation initiation site, gave the same results as the full-length syncoilin antibody, indicating that no aberrant syncoilin protein could be detected in sync-/- tissues. Fig. 2Western blot analysis of syncoilin and associated muscle proteins. Images show altered syncoilin expression in +/+, +/-, and -/- animals, without a resultant change in syncoilin-associated proteins
###end p 47
###begin p 48
Western blot analysis of syncoilin and associated muscle proteins. Images show altered syncoilin expression in +/+, +/-, and -/- animals, without a resultant change in syncoilin-associated proteins
###end p 48
###begin title 49
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Analysis of syncoilin-binding proteins and other muscle proteins in sync-/- mice
###end title 49
###begin p 50
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync</italic>
###xml 174 181 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 268 275 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 280 287 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 327 328 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 464 465 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 442 447 <span type="species:ncbi:10090">mouse</span>
DAPC-associated and syncoilin-binding partner proteins were quantified by Western blotting from total skeletal and cardiac muscle protein prepared from sync+/+, sync+/-, and sync-/- mice. Binding partners of syncoilin, desmin and alpha-dystrobrevin were unaffected in sync+/+ and sync-/- mouse skeletal or cardiac muscle (Fig. 2). An antibody recognizing synemin isoforms H and M revealed no variation in muscles from the different syncoilin mouse genotypes (Fig. 2). Equal protein loading was demonstrated by similar alpha-actinin levels between samples.
###end p 50
###begin p 51
###xml 316 323 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 328 335 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 533 540 529 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 545 552 541 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 822 829 814 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 834 841 826 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 858 859 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 862 868 854 860 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 944 951 936 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 956 963 948 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 1050 1057 1042 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 1081 1088 1073 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 1203 1204 1191 1192 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1246 1247 1234 1235 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1286 1287 1274 1275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1321 1322 1309 1310 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1353 1354 1341 1342 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 868 1389 860 1373 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52">Immunostaining of single-fiber preparations from flexor digitalis brevis in <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. Localization of syncoilin to the Z-lines, sarcolemma, and MTJ is evident in the <italic>sync+/+</italic> animal and lost in the <italic>sync&#8722;/&#8722;</italic> animal. Desmin and &#945;-actinin organization shows no evidence of disruption as a result of syncoilin ablation. (<bold>a</bold>) Syncoilin staining across whole fiber. (<bold>b</bold>) Desmin staining across whole fiber. (<bold>c</bold>) Syncoilin staining at Z-lines. (<bold>d</bold>) Desmin staining at Z-lines. (<bold>e</bold>) &#945;-Actinin staining at Z-lines</p>
###xml 868 1389 860 1373 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52">Immunostaining of single-fiber preparations from flexor digitalis brevis in <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. Localization of syncoilin to the Z-lines, sarcolemma, and MTJ is evident in the <italic>sync+/+</italic> animal and lost in the <italic>sync&#8722;/&#8722;</italic> animal. Desmin and &#945;-actinin organization shows no evidence of disruption as a result of syncoilin ablation. (<bold>a</bold>) Syncoilin staining across whole fiber. (<bold>b</bold>) Desmin staining across whole fiber. (<bold>c</bold>) Syncoilin staining at Z-lines. (<bold>d</bold>) Desmin staining at Z-lines. (<bold>e</bold>) &#945;-Actinin staining at Z-lines</p></caption>
###xml 1389 1389 1373 1373 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="335_2008_9120_Fig3_HTML" id="MO3"/>
###xml 862 1389 854 1373 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="52">Immunostaining of single-fiber preparations from flexor digitalis brevis in <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. Localization of syncoilin to the Z-lines, sarcolemma, and MTJ is evident in the <italic>sync+/+</italic> animal and lost in the <italic>sync&#8722;/&#8722;</italic> animal. Desmin and &#945;-actinin organization shows no evidence of disruption as a result of syncoilin ablation. (<bold>a</bold>) Syncoilin staining across whole fiber. (<bold>b</bold>) Desmin staining across whole fiber. (<bold>c</bold>) Syncoilin staining at Z-lines. (<bold>d</bold>) Desmin staining at Z-lines. (<bold>e</bold>) &#945;-Actinin staining at Z-lines</p></caption><graphic position="anchor" xlink:href="335_2008_9120_Fig3_HTML" id="MO3"/></fig>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
To assess if the absence of syncoilin affects the subcellular localization of syncoilin-binding proteins, the sarcomeric Z-lines, or other cytoskeletal proteins, we performed immunofluorescence on isolated myofibers. Fibers immunostained for desmin revealed no change in their normal location, with fibers from both sync+/+ and sync-/- mice showing normal localization to Z-lines and myotendinous junctions (ends of myofibers) (Fig. 3). alpha-Dystrobrevin immunostaining (data not shown) also exhibited a normal distribution in both sync+/+ and sync-/- fiber preparations. Thus, the subcellular localization of known syncoilin-binding partners is not dependent on the presence of syncoilin in muscle. Immunostaining of fibers for the Z-line protein alpha-actinin gave the expected Z-disc striated pattern staining in both sync+/+ and sync-/- myofibers (Fig. 3). Fig. 3Immunostaining of single-fiber preparations from flexor digitalis brevis in sync+/+ and sync-/- mice. Localization of syncoilin to the Z-lines, sarcolemma, and MTJ is evident in the sync+/+ animal and lost in the sync-/- animal. Desmin and alpha-actinin organization shows no evidence of disruption as a result of syncoilin ablation. (a) Syncoilin staining across whole fiber. (b) Desmin staining across whole fiber. (c) Syncoilin staining at Z-lines. (d) Desmin staining at Z-lines. (e) alpha-Actinin staining at Z-lines
###end p 51
###begin p 52
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 182 189 182 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 213 220 213 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 335 336 331 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 378 379 374 375 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 418 419 414 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 453 454 449 450 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 485 486 481 482 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Immunostaining of single-fiber preparations from flexor digitalis brevis in sync+/+ and sync-/- mice. Localization of syncoilin to the Z-lines, sarcolemma, and MTJ is evident in the sync+/+ animal and lost in the sync-/- animal. Desmin and alpha-actinin organization shows no evidence of disruption as a result of syncoilin ablation. (a) Syncoilin staining across whole fiber. (b) Desmin staining across whole fiber. (c) Syncoilin staining at Z-lines. (d) Desmin staining at Z-lines. (e) alpha-Actinin staining at Z-lines
###end p 52
###begin title 53
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Morphology of skeletal and cardiac muscle in sync-/- mice
###end title 53
###begin p 54
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 191 198 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 405 411 405 411 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 517 524 517 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 529 536 529 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 411 602 411 602 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="55">Hematoxylin and eosin staining of highly solicited muscles, soleus, diaphragm, and heart, from 8-week-old <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. No morphologic differences were noticed in any muscle types</p>
###xml 411 602 411 602 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="55">Hematoxylin and eosin staining of highly solicited muscles, soleus, diaphragm, and heart, from 8-week-old <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. No morphologic differences were noticed in any muscle types</p></caption>
###xml 602 602 602 602 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="335_2008_9120_Fig4_HTML" id="MO4"/>
###xml 405 602 405 602 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="55">Hematoxylin and eosin staining of highly solicited muscles, soleus, diaphragm, and heart, from 8-week-old <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. No morphologic differences were noticed in any muscle types</p></caption><graphic position="anchor" xlink:href="335_2008_9120_Fig4_HTML" id="MO4"/></fig>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
We examined the morphology of the more highly active muscles in 8-week-old mice by light microscopy of hematoxylin and eosin-stained sections of soleus, diaphragm, and heart from sync+/+ and sync-/- mice (Fig. 4). Histologic analysis revealed no gross differences between genotypes, and there was no sign of any dystrophic features or abnormal morphology in skeletal and cardiac muscle from sync-/- mice. Fig. 4Hematoxylin and eosin staining of highly solicited muscles, soleus, diaphragm, and heart, from 8-week-old sync+/+ and sync-/- mice. No morphologic differences were noticed in any muscle types
###end p 54
###begin p 55
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Hematoxylin and eosin staining of highly solicited muscles, soleus, diaphragm, and heart, from 8-week-old sync+/+ and sync-/- mice. No morphologic differences were noticed in any muscle types
###end p 55
###begin title 56
Absence of syncoilin reduces contractile function in skeletal muscles
###end title 56
###begin p 57
###xml 188 195 188 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 200 207 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 310 317 310 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 507 514 507 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 531 532 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 550 551 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 654 661 654 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 666 673 666 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 689 695 689 695 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 806 813 806 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 818 825 818 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 849 856 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 900 901 900 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 913 920 913 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 937 938 937 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 942 943 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 695 950 695 950 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="58">Contractile parameters of muscles from 8-week-old mice. Maximum isometric force of EDL and soleus muscles from <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. EDL muscles from <italic>sync&#8722;/&#8722;</italic> mice generated 27.9% less force (25.86&#160;N/cm<sup>2</sup>) than from <italic>sync+/+</italic> mice (35.89&#160;N/cm<sup>2</sup>). *<italic>p</italic>&#160;&lt;&#160;0.05</p>
###xml 695 950 695 950 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="58">Contractile parameters of muscles from 8-week-old mice. Maximum isometric force of EDL and soleus muscles from <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. EDL muscles from <italic>sync&#8722;/&#8722;</italic> mice generated 27.9% less force (25.86&#160;N/cm<sup>2</sup>) than from <italic>sync+/+</italic> mice (35.89&#160;N/cm<sup>2</sup>). *<italic>p</italic>&#160;&lt;&#160;0.05</p></caption>
###xml 950 950 950 950 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="335_2008_9120_Fig5_HTML" id="MO5"/>
###xml 689 950 689 950 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="58">Contractile parameters of muscles from 8-week-old mice. Maximum isometric force of EDL and soleus muscles from <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. EDL muscles from <italic>sync&#8722;/&#8722;</italic> mice generated 27.9% less force (25.86&#160;N/cm<sup>2</sup>) than from <italic>sync+/+</italic> mice (35.89&#160;N/cm<sup>2</sup>). *<italic>p</italic>&#160;&lt;&#160;0.05</p></caption><graphic position="anchor" xlink:href="335_2008_9120_Fig5_HTML" id="MO5"/></fig>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
To investigate the effect of syncoilin ablation on maximum isometric force generation, we measured force production in isolated soleus and extensor digitorum (EDL) muscles from 8-week-old sync+/+ and sync-/- mice. Four EDL muscles were assayed for each genotype. For the soleus analysis, eight sync+/+ and six sync-/- muscles were assayed. Isometric contractile testing of EDL muscles from sync-/- mice revealed a strongly significant decrease in normalized maximum force generation of -27.9% compared with sync+/+ mice (25.86 N/cm2 vs. 35.89 N/cm2; p < 0.05) (Fig. 6a), whereas there was no significant difference observed between the soleus muscles of sync+/+ and sync-/- mice (Fig. 5). Fig. 5Contractile parameters of muscles from 8-week-old mice. Maximum isometric force of EDL and soleus muscles from sync+/+ and sync-/- mice. EDL muscles from sync-/- mice generated 27.9% less force (25.86 N/cm2) than from sync+/+ mice (35.89 N/cm2). *p < 0.05
###end p 57
###begin p 58
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 218 225 218 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 242 243 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
Contractile parameters of muscles from 8-week-old mice. Maximum isometric force of EDL and soleus muscles from sync+/+ and sync-/- mice. EDL muscles from sync-/- mice generated 27.9% less force (25.86 N/cm2) than from sync+/+ mice (35.89 N/cm2). *p < 0.05
###end p 58
###begin title 59
Ablation of syncoilin does not elicit a morphologic change in the rate of myoregeneration
###end title 59
###begin p 60
###xml 258 265 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 270 277 270 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 584 591 584 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 596 603 596 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 613 619 613 619 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 620 621 620 621 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 725 728 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n&#160;=</italic>
###xml 1002 1009 1001 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 1014 1021 1013 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 1029 1030 1028 1029 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1280 1283 1279 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n&#160;=</italic>
###xml 1380 1387 1379 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 1392 1399 1391 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 619 1407 619 1406 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="61">(<bold>a</bold>) Regeneration of tibialis anterior muscle following treatment with cardiotoxin. Representative images (<italic>n&#160;=</italic>&#160;3 for each genotype at each time point) of hemotoxylin and eosin staining of 9&#8211;12-&#956;m cryosections taken from animals at 1, 3, 5, 7, and 21&#160;days after toxin administration. No obvious difference in degeneration, basophilic infiltration, or regeneration was noticed between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. (<bold>b</bold>) Myogenic differentiation analysis. Semiquantitative PCR analysis of p21CIP1, p27KIP1, p57KIP2, and myogenin RNA transcript levels in tibialis anterior at 1, 3, 5, and 7&#160;days following cardiotoxin administration. Images (which are representative of <italic>n&#160;=</italic>&#160;3 for each genotype at each time point) indicate no difference in regeneration kinetics between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> animals</p>
###xml 619 1407 619 1406 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="61">(<bold>a</bold>) Regeneration of tibialis anterior muscle following treatment with cardiotoxin. Representative images (<italic>n&#160;=</italic>&#160;3 for each genotype at each time point) of hemotoxylin and eosin staining of 9&#8211;12-&#956;m cryosections taken from animals at 1, 3, 5, 7, and 21&#160;days after toxin administration. No obvious difference in degeneration, basophilic infiltration, or regeneration was noticed between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. (<bold>b</bold>) Myogenic differentiation analysis. Semiquantitative PCR analysis of p21CIP1, p27KIP1, p57KIP2, and myogenin RNA transcript levels in tibialis anterior at 1, 3, 5, and 7&#160;days following cardiotoxin administration. Images (which are representative of <italic>n&#160;=</italic>&#160;3 for each genotype at each time point) indicate no difference in regeneration kinetics between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> animals</p></caption>
###xml 1407 1407 1406 1406 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="335_2008_9120_Fig6_HTML" id="MO6"/>
###xml 613 1407 613 1406 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="61">(<bold>a</bold>) Regeneration of tibialis anterior muscle following treatment with cardiotoxin. Representative images (<italic>n&#160;=</italic>&#160;3 for each genotype at each time point) of hemotoxylin and eosin staining of 9&#8211;12-&#956;m cryosections taken from animals at 1, 3, 5, 7, and 21&#160;days after toxin administration. No obvious difference in degeneration, basophilic infiltration, or regeneration was noticed between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. (<bold>b</bold>) Myogenic differentiation analysis. Semiquantitative PCR analysis of p21CIP1, p27KIP1, p57KIP2, and myogenin RNA transcript levels in tibialis anterior at 1, 3, 5, and 7&#160;days following cardiotoxin administration. Images (which are representative of <italic>n&#160;=</italic>&#160;3 for each genotype at each time point) indicate no difference in regeneration kinetics between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> animals</p></caption><graphic position="anchor" xlink:href="335_2008_9120_Fig6_HTML" id="MO6"/></fig>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
To investigate any changes in muscle regeneration due to the absence of syncoilin expression, we assessed regeneration at five time points, 1, 3, 5, 7, and 21 days, following the intramuscular administration of cardiotoxin to the tibialis anterior muscle in sync+/+ and sync-/- mice. Figure 6a shows representative images of muscle regeneration from the sync+/+ and sync-/- groups (n = 3 for each genotype) across the five time points. No obvious differences in degeneration, infiltration, or regeneration (including the number of centralized nuclei at 21 days) were observed between sync+/+ and sync-/- animals. Fig. 6(a) Regeneration of tibialis anterior muscle following treatment with cardiotoxin. Representative images (n = 3 for each genotype at each time point) of hemotoxylin and eosin staining of 9-12-mum cryosections taken from animals at 1, 3, 5, 7, and 21 days after toxin administration. No obvious difference in degeneration, basophilic infiltration, or regeneration was noticed between sync+/+ and sync-/- mice. (b) Myogenic differentiation analysis. Semiquantitative PCR analysis of p21CIP1, p27KIP1, p57KIP2, and myogenin RNA transcript levels in tibialis anterior at 1, 3, 5, and 7 days following cardiotoxin administration. Images (which are representative of n = 3 for each genotype at each time point) indicate no difference in regeneration kinetics between sync+/+ and sync-/- animals
###end p 60
###begin p 61
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n&#160;=</italic>
###xml 383 390 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 395 402 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 410 411 409 410 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 661 664 660 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n&#160;=</italic>
###xml 761 768 760 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 773 780 772 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
(a) Regeneration of tibialis anterior muscle following treatment with cardiotoxin. Representative images (n = 3 for each genotype at each time point) of hemotoxylin and eosin staining of 9-12-mum cryosections taken from animals at 1, 3, 5, 7, and 21 days after toxin administration. No obvious difference in degeneration, basophilic infiltration, or regeneration was noticed between sync+/+ and sync-/- mice. (b) Myogenic differentiation analysis. Semiquantitative PCR analysis of p21CIP1, p27KIP1, p57KIP2, and myogenin RNA transcript levels in tibialis anterior at 1, 3, 5, and 7 days following cardiotoxin administration. Images (which are representative of n = 3 for each genotype at each time point) indicate no difference in regeneration kinetics between sync+/+ and sync-/- animals
###end p 61
###begin title 62
Ablation of syncoilin does not elicit an alteration in markers of myogenic differentiation
###end title 62
###begin p 63
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 109 116 109 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2007</xref>
###xml 697 704 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 709 716 709 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
To investigate any potential difference in the kinetics of skeletal myocyte regeneration between sync+/+ and sync-/- animals, we performed a semiquantitative assessment of the relative RNA levels of the cell cycle-dependent kinase inhibitors p21CIP1, p27KIP1, p57KIP2 and myogenin in cardiotoxin-treated tibialis anterior muscle at 1, 3, 5, and 7 days after administration. An increase in cell cycle-dependent kinase inhibitors can be correlated with the initiation of myogenic differentiation at the expense of cell cycling. As such, these transcript levels can be used as markers of myoregeneration kinetics (Koo et al. 2007). No obvious difference in transcript levels was detected between the sync+/+ and sync-/- animals, indicating that the regeneration kinetics of skeletal muscle regeneration are not altered by the ablation of syncoilin (Fig. 6b).
###end p 63
###begin title 64
Ablation of syncoilin does not produce a statistically significant difference in voluntary wheel running
###end title 64
###begin p 65
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7</xref>
###xml 371 372 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 489 496 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 501 508 501 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 517 523 517 523 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;7</label>
###xml 572 579 572 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 584 591 584 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 523 683 523 683 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="66">Seven-day analysis of voluntary wheel running in <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. No significant difference was detected in the total activity levels of the two groups</p>
###xml 523 683 523 683 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="66">Seven-day analysis of voluntary wheel running in <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. No significant difference was detected in the total activity levels of the two groups</p></caption>
###xml 683 683 683 683 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="335_2008_9120_Fig7_HTML" id="MO7"/>
###xml 517 683 517 683 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig7"><label>Fig.&#160;7</label><caption><p textid="66">Seven-day analysis of voluntary wheel running in <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice. No significant difference was detected in the total activity levels of the two groups</p></caption><graphic position="anchor" xlink:href="335_2008_9120_Fig7_HTML" id="MO7"/></fig>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
A strong interanimal variation in running levels was identified in both groups (sync+/+ and sync-/-) of age- and sex-matched mice. Total individual (A) and group average (B) revolution counts are shown in Fig. 7 Individual cage positions are presented in paired form to compensate for any potential differential effect in environment. Two-tailed analysis using Student's t test did not identify a statistically significant difference between the averaged activity scores (p = 0.57) of the sync+/+ and sync-/- groups. Fig. 7Seven-day analysis of voluntary wheel running in sync+/+ and sync-/- mice. No significant difference was detected in the total activity levels of the two groups
###end p 65
###begin p 66
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Seven-day analysis of voluntary wheel running in sync+/+ and sync-/- mice. No significant difference was detected in the total activity levels of the two groups
###end p 66
###begin title 67
Ablation of syncoilin induces increased muscle damage without producing an observable difference in enforced treadmill running ability
###end title 67
###begin p 68
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 130 137 130 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 235 242 235 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig8" ref-type="fig">8</xref>
###xml 617 624 617 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 629 636 629 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 736 743 736 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 748 755 748 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 904 911 904 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 920 926 920 926 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;8</label>
###xml 1059 1066 1059 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 1071 1078 1071 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 926 1232 926 1232 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="69">Histologic analysis of tibialis anterior (TA), soleus (SOL), and extensor digitorum longus (EDL) showing no overt difference between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice (as assessed by hemotoxylin and eosin staining and Evans Blue staining). Images are representative of sections taken from three animals per genotype</p>
###xml 926 1232 926 1232 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="69">Histologic analysis of tibialis anterior (TA), soleus (SOL), and extensor digitorum longus (EDL) showing no overt difference between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice (as assessed by hemotoxylin and eosin staining and Evans Blue staining). Images are representative of sections taken from three animals per genotype</p></caption>
###xml 1232 1232 1232 1232 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="335_2008_9120_Fig8_HTML" id="MO8"/>
###xml 920 1232 920 1232 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig8"><label>Fig.&#160;8</label><caption><p textid="69">Histologic analysis of tibialis anterior (TA), soleus (SOL), and extensor digitorum longus (EDL) showing no overt difference between <italic>sync+/+</italic> and <italic>sync&#8722;/&#8722;</italic> mice (as assessed by hemotoxylin and eosin staining and Evans Blue staining). Images are representative of sections taken from three animals per genotype</p></caption><graphic position="anchor" xlink:href="335_2008_9120_Fig8_HTML" id="MO8"/></fig>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
An analysis of the enforced exercise capacity of sync+/+ and sync-/- mice failed to demonstrate a reduction in the ability of the sync-/- group to complete the prescribed exercise protocols. Eighty-three percent of sync+/+ and 100% of sync-/- mice successfully completed the final 60-min exhaustion test, reaching a maximum speed of 32 m/min after 60 min of running. All animals continued to gain weight normally over the course of the study (data not shown). Figure 8 shows the results of a histologic examination of muscle morphology following 15 running sessions. No obvious differences in the gross morphology of sync+/+ and sync-/- transverse sections were detected. A very small number of centralized nuclei were detected in both sync+/+ and sync-/- tibialis anterior sections. Evans Blue staining of isolated muscle did not indicate increased dye penetration (and therefore sarcolemmal damage) in sync-/- muscle. Fig. 8Histologic analysis of tibialis anterior (TA), soleus (SOL), and extensor digitorum longus (EDL) showing no overt difference between sync+/+ and sync-/- mice (as assessed by hemotoxylin and eosin staining and Evans Blue staining). Images are representative of sections taken from three animals per genotype
###end p 68
###begin p 69
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
Histologic analysis of tibialis anterior (TA), soleus (SOL), and extensor digitorum longus (EDL) showing no overt difference between sync+/+ and sync-/- mice (as assessed by hemotoxylin and eosin staining and Evans Blue staining). Images are representative of sections taken from three animals per genotype
###end p 69
###begin p 70
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 270 277 270 277 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 277 318 277 318 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="71">Serum CK levels from running mouse cohort</p>
###xml 277 318 277 318 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="71">Serum CK levels from running mouse cohort</p></caption>
###xml 318 326 318 326 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mouse ID</th>
###xml 326 334 326 334 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Genotype</th>
###xml 334 340 334 340 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">CK U/I</th>
###xml 340 348 340 348 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mouse ID</th>
###xml 348 356 348 356 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Genotype</th>
###xml 356 362 356 362 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">CK U/I</th>
###xml 318 362 318 362 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Mouse ID</th><th align="left">Genotype</th><th align="left">CK U/I</th><th align="left">Mouse ID</th><th align="left">Genotype</th><th align="left">CK U/I</th></tr>
###xml 318 362 318 362 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Mouse ID</th><th align="left">Genotype</th><th align="left">CK U/I</th><th align="left">Mouse ID</th><th align="left">Genotype</th><th align="left">CK U/I</th></tr></thead>
###xml 362 363 362 363 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0</td>
###xml 363 366 363 366 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+/+</td>
###xml 366 369 366 369 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">188</td>
###xml 369 370 369 370 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0</td>
###xml 370 373 370 373 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;/&#8722;</td>
###xml 373 376 373 376 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">741</td>
###xml 362 376 362 376 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">0</td><td align="left">+/+</td><td align="left">188</td><td align="left">0</td><td align="left">&#8722;/&#8722;</td><td align="left">741</td></tr>
###xml 376 377 376 377 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 377 380 377 380 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+/+</td>
###xml 380 383 380 383 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">447</td>
###xml 383 384 383 384 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 384 387 384 387 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;/&#8722;</td>
###xml 387 391 387 391 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1161</td>
###xml 376 391 376 391 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">1</td><td align="left">+/+</td><td align="left">447</td><td align="left">1</td><td align="left">&#8722;/&#8722;</td><td align="left">1161</td></tr>
###xml 391 392 391 392 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 392 395 392 395 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+/+</td>
###xml 395 398 395 398 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">704</td>
###xml 398 399 398 399 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 399 402 399 402 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;/&#8722;</td>
###xml 402 405 402 405 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">145</td>
###xml 391 405 391 405 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">3</td><td align="left">+/+</td><td align="left">704</td><td align="left">3</td><td align="left">&#8722;/&#8722;</td><td align="left">145</td></tr>
###xml 405 406 405 406 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4</td>
###xml 406 409 406 409 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+/+</td>
###xml 409 412 409 412 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">410</td>
###xml 412 413 412 413 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4</td>
###xml 413 416 413 416 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;/&#8722;</td>
###xml 416 420 416 420 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1771</td>
###xml 405 420 405 420 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">4</td><td align="left">+/+</td><td align="left">410</td><td align="left">4</td><td align="left">&#8722;/&#8722;</td><td align="left">1771</td></tr>
###xml 420 422 420 422 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10</td>
###xml 422 425 422 425 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+/+</td>
###xml 425 428 425 428 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">184</td>
###xml 428 430 428 430 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10</td>
###xml 430 433 430 433 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;/&#8722;</td>
###xml 433 437 433 437 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1545</td>
###xml 420 437 420 437 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">10</td><td align="left">+/+</td><td align="left">184</td><td align="left">10</td><td align="left">&#8722;/&#8722;</td><td align="left">1545</td></tr>
###xml 437 439 437 439 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">30</td>
###xml 439 442 439 442 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">+/+</td>
###xml 442 445 442 445 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">243</td>
###xml 445 447 445 447 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">30</td>
###xml 447 450 447 450 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8722;/&#8722;</td>
###xml 450 453 450 453 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">616</td>
###xml 437 453 437 453 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">30</td><td align="left">+/+</td><td align="left">243</td><td align="left">30</td><td align="left">&#8722;/&#8722;</td><td align="left">616</td></tr>
###xml 453 464 453 464 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">+/+ Average</td>
###xml 464 469 464 469 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">362.6</td>
###xml 469 480 469 480 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">&#8722;/&#8722; Average</td>
###xml 480 485 480 485 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">996.5</td>
###xml 453 485 453 485 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="2">+/+ Average</td><td align="left">362.6</td><td align="left" colspan="2">&#8722;/&#8722; Average</td><td align="left">996.5</td></tr>
###xml 362 485 362 485 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">0</td><td align="left">+/+</td><td align="left">188</td><td align="left">0</td><td align="left">&#8722;/&#8722;</td><td align="left">741</td></tr><tr><td align="left">1</td><td align="left">+/+</td><td align="left">447</td><td align="left">1</td><td align="left">&#8722;/&#8722;</td><td align="left">1161</td></tr><tr><td align="left">3</td><td align="left">+/+</td><td align="left">704</td><td align="left">3</td><td align="left">&#8722;/&#8722;</td><td align="left">145</td></tr><tr><td align="left">4</td><td align="left">+/+</td><td align="left">410</td><td align="left">4</td><td align="left">&#8722;/&#8722;</td><td align="left">1771</td></tr><tr><td align="left">10</td><td align="left">+/+</td><td align="left">184</td><td align="left">10</td><td align="left">&#8722;/&#8722;</td><td align="left">1545</td></tr><tr><td align="left">30</td><td align="left">+/+</td><td align="left">243</td><td align="left">30</td><td align="left">&#8722;/&#8722;</td><td align="left">616</td></tr><tr><td align="left" colspan="2">+/+ Average</td><td align="left">362.6</td><td align="left" colspan="2">&#8722;/&#8722; Average</td><td align="left">996.5</td></tr></tbody>
###xml 318 485 318 485 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Mouse ID</th><th align="left">Genotype</th><th align="left">CK U/I</th><th align="left">Mouse ID</th><th align="left">Genotype</th><th align="left">CK U/I</th></tr></thead><tbody><tr><td align="left">0</td><td align="left">+/+</td><td align="left">188</td><td align="left">0</td><td align="left">&#8722;/&#8722;</td><td align="left">741</td></tr><tr><td align="left">1</td><td align="left">+/+</td><td align="left">447</td><td align="left">1</td><td align="left">&#8722;/&#8722;</td><td align="left">1161</td></tr><tr><td align="left">3</td><td align="left">+/+</td><td align="left">704</td><td align="left">3</td><td align="left">&#8722;/&#8722;</td><td align="left">145</td></tr><tr><td align="left">4</td><td align="left">+/+</td><td align="left">410</td><td align="left">4</td><td align="left">&#8722;/&#8722;</td><td align="left">1771</td></tr><tr><td align="left">10</td><td align="left">+/+</td><td align="left">184</td><td align="left">10</td><td align="left">&#8722;/&#8722;</td><td align="left">1545</td></tr><tr><td align="left">30</td><td align="left">+/+</td><td align="left">243</td><td align="left">30</td><td align="left">&#8722;/&#8722;</td><td align="left">616</td></tr><tr><td align="left" colspan="2">+/+ Average</td><td align="left">362.6</td><td align="left" colspan="2">&#8722;/&#8722; Average</td><td align="left">996.5</td></tr></tbody></table>
###xml 270 485 270 485 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="71">Serum CK levels from running mouse cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Mouse ID</th><th align="left">Genotype</th><th align="left">CK U/I</th><th align="left">Mouse ID</th><th align="left">Genotype</th><th align="left">CK U/I</th></tr></thead><tbody><tr><td align="left">0</td><td align="left">+/+</td><td align="left">188</td><td align="left">0</td><td align="left">&#8722;/&#8722;</td><td align="left">741</td></tr><tr><td align="left">1</td><td align="left">+/+</td><td align="left">447</td><td align="left">1</td><td align="left">&#8722;/&#8722;</td><td align="left">1161</td></tr><tr><td align="left">3</td><td align="left">+/+</td><td align="left">704</td><td align="left">3</td><td align="left">&#8722;/&#8722;</td><td align="left">145</td></tr><tr><td align="left">4</td><td align="left">+/+</td><td align="left">410</td><td align="left">4</td><td align="left">&#8722;/&#8722;</td><td align="left">1771</td></tr><tr><td align="left">10</td><td align="left">+/+</td><td align="left">184</td><td align="left">10</td><td align="left">&#8722;/&#8722;</td><td align="left">1545</td></tr><tr><td align="left">30</td><td align="left">+/+</td><td align="left">243</td><td align="left">30</td><td align="left">&#8722;/&#8722;</td><td align="left">616</td></tr><tr><td align="left" colspan="2">+/+ Average</td><td align="left">362.6</td><td align="left" colspan="2">&#8722;/&#8722; Average</td><td align="left">996.5</td></tr></tbody></table></table-wrap>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
CK analysis of serum taken from sync+/+ and sync-/- animals (n = 6 per genotype) immediately following the completion of their running protocol showed a significant (p < 0.05, two-tailed Student's t test) increase in serum CK levels in the sync-/- population (Table 1). Table 1Serum CK levels from running mouse cohortMouse IDGenotypeCK U/IMouse IDGenotypeCK U/I0+/+1880-/-7411+/+4471-/-11613+/+7043-/-1454+/+4104-/-177110+/+18410-/-154530+/+24330-/-616+/+ Average362.6-/- Average996.5
###end p 70
###begin p 71
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Serum CK levels from running mouse cohort
###end p 71
###begin title 72
Discussion
###end title 72
###begin p 73
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 419 423 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2001</xref>
###xml 437 441 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">2002</xref>
###xml 527 532 <span type="species:ncbi:10090">mouse</span>
Syncoilin is a 64-kDa intermediate filament-like protein expressed in skeletal and cardiac muscle that is found to be enriched at the perinucleus, the Z-lines, and at the sarcolemma and neuromuscular junction (Newey et al. 2001). Previous studies have shown that syncoilin interacts with both alpha-dystrobrevin (a DAPC component) and desmin (the major intermediate filament expressed in mature myocytes) (Newey et al. 2001; Poon et al. 2002). By ablating in excess of 80% of the syncoilin-coding sequence, we have generated a mouse model that is null (-/-) for syncoilin expression.
###end p 73
###begin p 74
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 243 250 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 255 262 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 439 446 431 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 451 458 443 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 611 612 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 617 618 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
Developmentally, sync+/+ and sync-/- mice are indistinguishable. Protein expression analysis of the syncoilin-binding partners desmin and alpha-dystrobrevin failed to demonstrate a difference in their net concentrations in muscle derived from sync+/+ and sync-/- mice. Immunofluorescent staining of single-fiber preparations of flexor digitalis brevis muscle demonstrated no difference in desmin or alpha-dystrobrevin localization between sync+/+ and sync-/- mice. Together, these data indicate that syncoilin is not essential for either the correct cellular localization or expression of these proteins (Figs. 2 and 3).
###end p 74
###begin p 75
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">2006</xref>
###xml 392 399 392 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 404 411 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2007</xref>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
The treatment of skeletal muscle with myonecrotic cardiotoxin induces widespread necrosis followed by a well characterized cascade of satellite cell activation, proliferation, differentiation, and maturation (Shi and Garry 2006). Our histologic analysis of cardiotoxin-treated tibialis anterior muscle yielded no detectable difference in regenerating muscle at any of the time points between sync+/+ and sync-/- mice. Semiquantitative PCR analysis of myogenin, p21, p27, and p57 expression in cardiotoxin-treated tissue also failed to elicit a noticeable difference in transcript levels. When their expression is upregulated, these proteins act to initiate myogenic differentiation and prevent the cell from re-entering the cell replication cycle (Koo et al. 2007). These findings indicate that a lack of syncoilin does not obviously retard muscle tissue regeneration and that thus syncoilin is unlikely to play an essential role in this process. The results of both our voluntary running and enforced treadmill exercise studies indicate that phenotypically syncoilin is dispensable for the normal mechanical function of striated mucle under exercise conditions.
###end p 75
###begin p 76
###xml 156 163 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 182 189 182 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync</italic>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">2008</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">2008</xref>
Interestingly, an investigation of contractile function in isolated soleus and EDL demonstrated a reduction of nearly 30% in the maximum force generated by sync-/- EDL compared with sync+/+ EDL (although no difference in the soleus analysis) (Fig. 5). EDL comprises mostly fast (type II) myofibers, in contrast to soleus muscle which is populated mainly by slow (type I) myofibers. The reduction in maximum force generation seen in EDL may indicate that syncoilin plays varying roles or has a variable functional redundancy in different fiber types. The identification of a force reduction in sync-/- EDL is in accordance with a similar analysis performed by Zhang et al. (2008). Using an alternative syncoilin-null model (generated by the introduction of a point mutation resulting in the aberrant mRNA splicing of the second syncoilin exon), this study reinforces the findings presented in our own analysis, namely, that syncoilin appears to be largely redundant for striated muscle development and regeneration (Zhang et al. 2008).
###end p 76
###begin p 77
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
Our analysis of serum CK levels following 3 weeks of enforced treadmill exercise is the first report of a functionally induced myopathy deriving from an absence of syncoilin (Table 1). Elevated serum CK levels are widely used as a marker of sarcolemmal damage. This finding is in contrast to earlier studies performed on des-/- mice, which failed to exhibit an increase in serum CK levels after a bout of enforced treadmill exercise (Haulbold et al. 2003).
###end p 77
###begin p 78
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">1998</xref>
###xml 206 209 206 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">1998</xref>
###xml 353 359 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 210 215 <span type="species:ncbi:10090">mouse</span>
An analysis of serum CK levels in des-/- mice was performed immediately following and 24 h after a brief period of low-speed downhill running as described by Vilquin et al. (1998) for use in the dystrophin mdx mouse model (Haubold et al. 2003; Vilquin et al. 1998). The results of this study did not show a difference in CK levels between wild-type and des-/- animals either immediately after or 1 day after exercise.
###end p 78
###begin p 79
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">1998</xref>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2003</xref>
###xml 766 772 766 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">des&#8722;/&#8722;</italic>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 174 179 <span type="species:ncbi:10090">mouse</span>
###xml 225 230 <span type="species:ncbi:10090">mouse</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
The mdx mouse is used as a model of dystrophin ablation-induced muscular dystrophy and exhibits a severe myopathic phenotype (Vilquin et al. 1998). The phenotype of a des-/- mouse is far milder than that exhibited by the mdx mouse, although des-/- mice still exhibit a reduction in running ability when compared with wild-type animals (Haubold et al. 2003). At a molecular level, a loss of desmin does not appear to induce disruption of the essential DAPC as is seen with a loss of dystrophin. Although it is surprising that a loss of syncoilin induces an increase in serum CK levels whereas a loss of desmin does not (given the proposed role of syncoilin and the abundance of desmin in mature myocytes), it is a possibility that the exercise regimen applied to the des-/- mice was not sufficient in either duration or intensity to induce sufficient damage to cause mechanical stress.
###end p 79
###begin p 80
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">2007</xref>
The precise function of syncoilin remains undelineated. However, we do possess several pieces of evidence that can assist us in generating hypotheses about the role(s) of syncoilin in muscle. Given that syncoilin is a member of the IF protein family (at least at a sequence homology level), we can reasonably expect that it plays a role in line with that of other IF proteins, which, among others, involves protecting cells from mechanical stress (Parry et al. 2007). Syncoilin's association with the DAPC and other IF proteins (in particular, the finding that it binds to desmin) adds weight to it having a structural role in muscle. Our studies indicate that at least in an acute setting there are sufficient mechanisms in existence in myocytes to cope with a loss of syncoilin. One such potential compensatory mechanism may exist in skeletal muscle in the form of the type IV IF protein synemin, although it is worth noting that there are significant size and structural differences between these two IF proteins.
###end p 80
###begin p 81
###xml 142 146 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2008</xref>
###xml 313 317 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">1999</xref>
###xml 319 323 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2001</xref>
###xml 597 601 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2008</xref>
###xml 850 854 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 922 929 900 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Synemin is a large IF protein expressed in all types of human muscle cells as two splice variants, alpha-synemin and beta-synemin (Sun et al. 2008). Synemin has been shown to act as a binding partner for a range of cytoskeletal and structural proteins and contains a binding site for alpha-actinin (Bellin et al. 1999, 2001). Recent studies have indicated that the two variants may play different roles in muscle, with the ability to interact with vinculin and metavinculin limited to alpha-synemin, which contains an additional C-terminal 312-residue insert not found in beta-synemin (Sun et al. 2008). Importantly for our investigation of syncoilin, synemin has also been shown to act as a binding partner for desmin and alpha-dystrobrevin, and the spatial organization of synemin exhibits a number of parallels to that of syncoilin (Bhosle et al. 2006). As such, it has the potential to act in a compensatory role in a sync-/- system.
###end p 81
###begin p 82
###xml 163 170 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync+/+</italic>
###xml 175 182 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 238 245 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sync&#8722;/&#8722;</italic>
###xml 93 99 <span type="species:ncbi:9606">humans</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
Our Western blot analysis for both H and M variants (analogous to alpha and beta variants in humans) of synemin showed no difference in net protein levels between sync+/+ and sync-/- mice, indicating that a lack of overt phenotype in the sync-/- mouse is not due to compensation by synemin. It is possible, however, that the presence of synemin in what appears to be a similar role in muscle offsets or masks the deleterious effects of a loss of syncoilin, such that under normal laboratory cage or mild exercise conditions, syncoilin exhibits a degree of functional redundancy.
###end p 82
###begin p 83
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
In summary, our investigations show that we have generated a functional example of a syncoilin knockout mouse model. Syncoilin-null mice do not display an overt phenotype. An absence of syncoilin does not (in the proteins investigated in this study) induce a compensatory protein upregulation in skeletal muscle or the disruption of protein localization in isolated fibers. No difference in muscle regeneration following cardiotoxin-induced necrosis was observed, and an absence of syncoilin did not affect voluntary or enforced exercise capacity.
###end p 83
###begin p 84
The mechanical analysis of isolated muscle revealed a significant alteration in contractile properties, indicating that syncoilin may play a role in the lateral transmission of force across contractile tissues. Most interestingly, we have shown that under extended exercise conditions, an absence of syncoilin predisposes muscle to increased damage. Given the findings in this and other studies, it is possible that the role of syncoilin is analogous to that of "a single spoke in a wheel," in that its structural role is not appreciated (nor its absence noted) until significant levels of mechanical stress are applied to the syncoilin-deficient system.
###end p 84
###begin p 85
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
This work was supported by the Muscular Dystrophy Association USA and Association Francaise Contre les Myopathies. The authors are grateful to Dr. S. Peirson for providing valuable assistance with the monitored mouse running study, and to D. Jelfs for assistance with animal husbandry.
###end p 85
###begin p 86
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Effects of eccentric treadmill running on mouse soleus: degeneration/regeneration studies with Myf-5 and MyoD probes
###end article-title 88
###begin article-title 89
Molecular characteristics and interactions of the intermediate filament protein synemin. Interactions with alpha-actinin may anchor synemin-containing heterofilaments
###end article-title 89
###begin article-title 90
Synemin may function to directly link muscle intermediate filaments to both myofibrillar z-lines and costameres
###end article-title 90
###begin article-title 91
Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain
###end article-title 91
###begin article-title 92
Interactions of intermediate filament protein synemin with dystrophin and utrophin
###end article-title 92
###begin article-title 93
Beta-dystrobrevin, a member of the dystrophin-related protein family
###end article-title 93
###begin article-title 94
Function and genetics of dystrophin and dystrophin-related proteins in muscle
###end article-title 94
###begin article-title 95
Delayed dedifferentiation and retention of properties in dissociated adult skeletal muscle fibers in vitro
###end article-title 95
###begin article-title 96
###xml 36 44 <span type="species:ncbi:9606">patients</span>
Syncoilin upregulation in muscle of patients with neuromuscular disease
###end article-title 96
###begin article-title 97
Muscle intermediate filaments and their links to membranes and membranous organelles
###end article-title 97
###begin article-title 98
Desmin: molecular interactions and putative functions of the muscle intermediate filament protein
###end article-title 98
###begin article-title 99
Molecular mechanisms of muscular dystrophies: old and new players
###end article-title 99
###begin article-title 100
Loss of desmin leads to impaired voluntary wheel running and treadmill exercise performance
###end article-title 100
###begin article-title 101
The dystrolein, dystrophin and dystrobrevin superfamily: new paralogues and old isoforms
###end article-title 101
###begin article-title 102
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy
###end article-title 102
###begin article-title 103
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Bex1 knockout mice show altered skeletal muscle regeneration
###end article-title 103
###begin article-title 104
Tensile properties of single desmin intermediate filaments
###end article-title 104
###begin article-title 105
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Cardiovascular lesions and skeletal myopathy in mice lacking desmin
###end article-title 105
###begin article-title 106
Intermediate filament-like protein syncoilin in normal and myopathic striated muscle
###end article-title 106
###begin article-title 107
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Disruption of muscle architecture and myocardial degeneration in mice lacking desmin
###end article-title 107
###begin article-title 108
###xml 52 57 <span type="species:ncbi:9606">human</span>
Beta-synemin localizes to regions of high stress in human skeletal myofibers
###end article-title 108
###begin article-title 109
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch
###end article-title 109
###begin article-title 110
Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle
###end article-title 110
###begin article-title 111
Desmin-related myopathy: clinical, electrophysiological, radiological, neuropathological and genetic studies
###end article-title 111
###begin article-title 112
Towards a molecular description of intermediate filament structure and assembly
###end article-title 112
###begin article-title 113
Desminopathies in muscle disease
###end article-title 113
###begin article-title 114
Association of syncoilin and desmin: linking intermediate filament proteins to the dystrophin-associated protein complex
###end article-title 114
###begin article-title 115
Dystrobrevins in muscle and non-muscle tissues
###end article-title 115
###begin article-title 116
Muscle stem cells in development, regeneration, and disease
###end article-title 116
###begin article-title 117
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human alpha-synemin interacts directly with vinculin and metavinculin
###end article-title 117
###begin article-title 118
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise
###end article-title 118
###begin article-title 119
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
The action potential-evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres
###end article-title 119
###begin article-title 120
Syncoilin is required for generating maximum isometric stress in skeletal muscle but dispensable for muscle architecture
###end article-title 120
###begin p 121
K. J. A. McCullagh, B. Edwards, and M. W. Kemp contributed equally to this work.
###end p 121

